We aim to develop and validate our diagnostic platform as well as our diagnostic service for Alzheimer’s Disease by conducting several multicentric studies across the country with the highest qualitative and ethical standards.
In our current clinical studies, we focus on the biomarker profile of healthy subjects and patients with brain pathologies, such as Alzheimer’s. Following patient examination and comparison of the results to the current clinical standard, we collaborate with renowned clinical centers and leading Alzheimer’s institutes. This enables us to benefit from an outstanding scientific expertise.
Our clinical trials are partly funded by BMBF (German Federal Ministry of Education and Research).
Ismaninger Straße 22
Nasal secretion contains many exciting proteins. These can provide information about the presence of various diseases. For this purpose, we have developed a novel collection – and testing-procedure, which we would like to review – with your help.